Publicacións en colaboración con investigadores/as de Guangzhou Medical University (1)

2022

  1. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease

    JHEP REPORTS, Vol. 4, Núm. 1